595 related articles for article (PubMed ID: 20558530)
1. Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism.
Van Veldhoven PP
J Lipid Res; 2010 Oct; 51(10):2863-95. PubMed ID: 20558530
[TBL] [Abstract][Full Text] [Related]
2. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
[TBL] [Abstract][Full Text] [Related]
3. Human metabolism of phytanic acid and pristanic acid.
Verhoeven NM; Jakobs C
Prog Lipid Res; 2001 Nov; 40(6):453-66. PubMed ID: 11591435
[TBL] [Abstract][Full Text] [Related]
4. Fatty Acid Oxidation in Peroxisomes: Enzymology, Metabolic Crosstalk with Other Organelles and Peroxisomal Disorders.
Wanders RJA; Vaz FM; Waterham HR; Ferdinandusse S
Adv Exp Med Biol; 2020; 1299():55-70. PubMed ID: 33417207
[TBL] [Abstract][Full Text] [Related]
5. Stereochemistry of the peroxisomal branched-chain fatty acid alpha- and beta-oxidation systems in patients suffering from different peroxisomal disorders.
Ferdinandusse S; Rusch H; van Lint AE; Dacremont G; Wanders RJ; Vreken P
J Lipid Res; 2002 Mar; 43(3):438-44. PubMed ID: 11893780
[TBL] [Abstract][Full Text] [Related]
6. The metabolism of phytanic acid and pristanic acid in man: a review.
Verhoeven NM; Wanders RJ; Poll-The BT; Saudubray JM; Jakobs C
J Inherit Metab Dis; 1998 Oct; 21(7):697-728. PubMed ID: 9819701
[TBL] [Abstract][Full Text] [Related]
7. Mice with a deficiency in Peroxisomal Membrane Protein 4 (PXMP4) display mild changes in hepatic lipid metabolism.
Blankestijn M; Bloks VW; Struik D; Huijkman N; Kloosterhuis N; Wolters JC; Wanders RJA; Vaz FM; Islinger M; Kuipers F; van de Sluis B; Groen AK; Verkade HJ; Jonker JW
Sci Rep; 2022 Feb; 12(1):2512. PubMed ID: 35169201
[TBL] [Abstract][Full Text] [Related]
8. Peroxisomal fatty acid alpha- and beta-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases.
Wanders RJ; Vreken P; Ferdinandusse S; Jansen GA; Waterham HR; van Roermund CW; Van Grunsven EG
Biochem Soc Trans; 2001 May; 29(Pt 2):250-67. PubMed ID: 11356164
[TBL] [Abstract][Full Text] [Related]
9. The chemical biology of branched-chain lipid metabolism.
Mukherji M; Schofield CJ; Wierzbicki AS; Jansen GA; Wanders RJ; Lloyd MD
Prog Lipid Res; 2003 Sep; 42(5):359-76. PubMed ID: 12814641
[TBL] [Abstract][Full Text] [Related]
10. New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders.
Van Veldhoven PP
Verh K Acad Geneeskd Belg; 1998; 60(3):195-214. PubMed ID: 9803880
[TBL] [Abstract][Full Text] [Related]
11. Biochemistry of peroxisomes in health and disease.
Singh I
Mol Cell Biochem; 1997 Feb; 167(1-2):1-29. PubMed ID: 9059978
[TBL] [Abstract][Full Text] [Related]
12. Peroxisomal disorders: the single peroxisomal enzyme deficiencies.
Wanders RJ; Waterham HR
Biochim Biophys Acta; 2006 Dec; 1763(12):1707-20. PubMed ID: 17055078
[TBL] [Abstract][Full Text] [Related]
13. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system.
Reddy JK; Hashimoto T
Annu Rev Nutr; 2001; 21():193-230. PubMed ID: 11375435
[TBL] [Abstract][Full Text] [Related]
14. Peroxisomal beta-oxidation of branched chain fatty acids in rat liver. Evidence that carnitine palmitoyltransferase I prevents transport of branched chain fatty acids into mitochondria.
Singh H; Beckman K; Poulos A
J Biol Chem; 1994 Apr; 269(13):9514-20. PubMed ID: 8144536
[TBL] [Abstract][Full Text] [Related]
15. Metabolic aspects of peroxisomal disorders.
Wanders RJ; Jansen G; van Roermund CW; Denis S; Schutgens RB; Jakobs BS
Ann N Y Acad Sci; 1996 Dec; 804():450-60. PubMed ID: 8993564
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis.
Reddy JK
Am J Physiol Gastrointest Liver Physiol; 2001 Dec; 281(6):G1333-9. PubMed ID: 11705737
[TBL] [Abstract][Full Text] [Related]
17. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes.
Jansen GA; van den Brink DM; Ofman R; Draghici O; Dacremont G; Wanders RJ
Biochem Biophys Res Commun; 2001 May; 283(3):674-9. PubMed ID: 11341778
[TBL] [Abstract][Full Text] [Related]
18. Peroxisomes contain a specific phytanoyl-CoA/pristanoyl-CoA thioesterase acting as a novel auxiliary enzyme in alpha- and beta-oxidation of methyl-branched fatty acids in mouse.
Westin MAK; Hunt MC; Alexson SEH
J Biol Chem; 2007 Sep; 282(37):26707-26716. PubMed ID: 17613526
[TBL] [Abstract][Full Text] [Related]
19. Peroxisomes, lipid metabolism, and peroxisomal disorders.
Wanders RJ
Mol Genet Metab; 2004; 83(1-2):16-27. PubMed ID: 15464416
[TBL] [Abstract][Full Text] [Related]
20. Phytanic acid metabolism in health and disease.
Wanders RJ; Komen J; Ferdinandusse S
Biochim Biophys Acta; 2011 Sep; 1811(9):498-507. PubMed ID: 21683154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
